1 Department of Pharmacy Practice, College of Pharmacy, University of Utah, and Department of Neurology, Primary Children's Medical Center, Salt Lake City
In nine pediatric patients with seizure disorders, aged 8 months to 16
years, a single daily dose of phenobarbital was as effective in maintaining therapeutic serum concentrations as twice-daily dosing. There were no adverse reactions to the once-daily regimen, and no seizure activity occurred during the study as a result of the change in dosing pattern.